Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safe and tolerable dose of sunitinib when given
together with cisplatin and 5-fluorouracil in patients with advanced gastric cancer who have
not received prior chemotherapy for their advanced cancer.